<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39372968</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2515-1355</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Therapeutic advances in vaccines and immunotherapy</Title><ISOAbbreviation>Ther Adv Vaccines Immunother</ISOAbbreviation></Journal><ArticleTitle>COVID-19 vaccine coverage effectiveness among elderly with geographical information system mapping: what about Indonesia?</ArticleTitle><Pagination><StartPage>25151355241285379</StartPage><MedlinePgn>25151355241285379</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25151355241285379</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/25151355241285379</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The elderly are the next priority after health workers and public service workers get the COVID-19 vaccine to control morbidity and even mortality in the elderly who have a risk factor that is up to 60 times more severe than children.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study aimed to spatially analyze the effectiveness of COVID-19 vaccine coverage among the elderly in Indonesia with geographic information system (GIS) mapping and to analyze the relationship between COVID-19 vaccine coverage in the elderly with the COVID-19 cure rate.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">This quantitative study used secondary data on COVID-19 vaccination coverage in the elderly group of Central Java Province, Indonesia in 2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Data were analyzed using a simple linear correlation test to test the relationship between variables with a 1,774,396 elderly sample size, then distributed using mapping of COVID-19 vaccination coverage using a GIS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The relationship between COVID-19 vaccine dose-2 elderly coverage cure rate showed a strong relationship (<i>r</i> = 0.677) and a positive pattern. The coefficient value with a determination of 0.459 means that the regression line equation obtained can explain 45.90% of the variation in the COVID-19 cure rate. There was a significant relationship between COVID-19 vaccine elderly coverage and the COVID-19 cure rate (<i>p</i>-value = 0.005).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Clinicians and public health workers should continue to encourage elderly vaccination at all recommended doses for eligible individuals.</AbstractText><CopyrightInformation>© The Author(s), 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wulan</LastName><ForeName>Widya Ratna</ForeName><Initials>WR</Initials><Identifier Source="ORCID">0000-0001-9268-8962</Identifier><AffiliationInfo><Affiliation>Department of Health Information Management, Faculty of Health Science, Universitas Dian Nuswantoro, No 1-5, Nakula Street, Semarang District, Central Java 50131, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widianawati</LastName><ForeName>Evina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Health Science, Universitas Dian Nuswantoro, Semarang, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahyuni</LastName><ForeName>Anis Tri</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Faculty of Health Science, Universitas Dian Nuswantoro, Semarang, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Vaccines Immunother</MedlineTA><NlmUniqueID>101718382</NlmUniqueID><ISSNLinking>2515-1355</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>COVID-19 vaccine coverage effectiveness among elderly with geographical information system mapping: what about Indonesia? This research analyzed the Effectiveness of COVID-19 Vaccine Coverage among the Elderly in Indonesia with Geographic Information System Mapping and analyzed the relationship between COVID-19 Vaccine coverage in the elderly with the COVID-19 cure rate.</AbstractText><CopyrightInformation>© The Author(s), 2024.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">effectiveness</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">geographical information system</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39372968</ArticleId><ArticleId IdType="pmc">PMC11456189</ArticleId><ArticleId IdType="doi">10.1177/25151355241285379</ArticleId><ArticleId IdType="pii">10.1177_25151355241285379</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Ministry of Health RI. Circular Letter Hk.02.02/I/1727/2021 Regarding Phase 3 Vaccination for Vulnerable Communities and Other Communities and Implementation of Covid-19 Vaccination for Children 12–17 Years of Age Development, https://kesmas.kemkes.go.id/konten/105/0/surat-edaran-nomor-hk-02-02-i-1727-2021-tentang-vaksinasi-tahap-3-bagi-masyarakat-rentan-masyarakat-umum-lainnya-dan-anak-usia-12-17-tahun (2021, accessed 4 July 2021).</Citation></Reference><Reference><Citation>KPCPEN. #Infovaccine Pocket Guide V4 November, 2020.</Citation></Reference><Reference><Citation>
Directorate General of Disease Prevention and Control. Circular Letter Number HK.02.02/II/1406/2021 Regarding Acceleration of the Implementation of COVID-19 Vaccination in the Pre-Elderly Group and BPOM Results Regarding Astra Zeneca COVID-19 Vaccine. Indonesian Ministry of Health
2021; 2019: 2020–2021. https://inspektorat.madiunkota.go.id/wp-content/uploads/2021/05/PERCEPATAN-PELAKSANAAN-VAKSINASI-COVID-19-Pada-Kelompok-Lansia-dan-Hasil-BPOM-Terkait-Vaksin-COVID-19-Astra-Zeneca1.pdf (accessed 23 September 2024).</Citation></Reference><Reference><Citation>
Ministry of Health RI. Circular Letter Number: HK.02.02/II/368/2021 Regarding the Implementation of Covid-19 Vaccination in Elderly Target Groups, Comorbidities and Covid-19 Survivors as well as Delayed Targets, https://www.kemkes.go.id/article/view/19031800003/cegah-penyalahgunaan-narkoba-kemenkes-ajak-terapkan-germas.html%0Ahttps://www.depkes.go.id/article/view/18030500005/waspadai-peningkatan-penyakit-menular.html%0Ahttp://www.depkes.go.id/article/view/1707070 (2021, accessed 15 February 2021).</Citation></Reference><Reference><Citation>Pangestika L, Subiyanto S, Firdaus H. Web-based geographic information system application for the distribution of health workers in Semarang City. J Geod Undip 2017; 6(4): 26–34.</Citation></Reference><Reference><Citation>Dauria EF, Clemenzi-Allen A, Nowotny K, et al.. Increasing availability of COVID-19 vaccine to older adults under community supervision. Int J Prison Heal 2023; 6: 139–148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10114607</ArticleId><ArticleId IdType="pubmed">36367307</ArticleId></ArticleIdList></Reference><Reference><Citation>
Indonesian Ministry of Health. COVID-19 vaccination data, https://covid19.go.id/p/berita/data-vaksinasi-covid-19-update-17-januari-2022 (2022, accessed 17 January 2022).</Citation></Reference><Reference><Citation>Kemenkes ITAGI, WHO UNICEF. COVID-19 vaccine acceptance survey in Indonesia. In, 2020.</Citation></Reference><Reference><Citation>
Committee for COVID-19 Handling and National Economic Recovery. COVID-19 Vaccination Data (accessed 17 January 2022), https://covid19.go.id/artikel/2022/01/17/data-vaksinasi-covid-19-update-17-januari-2022 (2022).</Citation></Reference><Reference><Citation>
Ministry of Health. Circular Letter HK.02.01/I/1919 /2021 on Third dose vaccination for all health workers, health worker assistants and support personnel working in health service facilities. Vol 4247608.; 2021: 613–614. https://sehatnegeriku.kemkes.go.id/baca/umum/20210801/1838206/kemenkes-tegaskan-vaksinasi-booster-hanya-untuk-tenaga-kesehatan/ (accessed 01 August 2021).</Citation></Reference><Reference><Citation>Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Global Health Res Policy 2020; 6: 2019–2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7050114</ArticleId><ArticleId IdType="pubmed">32226823</ArticleId></ArticleIdList></Reference><Reference><Citation>
Indonesian Ministry of Health. Task force to accelerate the handling of COVID-19, http://www.covid-19.go.id/ (2022, accessed 13 January 2021).</Citation></Reference><Reference><Citation>Yuningsih A. Relationship between Knowledge and Readiness of the Elderly to Receive the COVID-19 Vaccine. Healthc Nurs J 2022; 4(2): 398–403.</Citation></Reference><Reference><Citation>Zhang L, Jiang L, Tian T, et al.. Efficacy and safety of COVID-19 Vaccination in older adults : a systematic review and meta-analysis. Vaccines (Basel) 2022; 11(1): 33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9862835</ArticleId><ArticleId IdType="pubmed">36679878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sales-moioli AIL, Galv LJ, Pinto TKB, et al.. Effectiveness of COVID-19 vaccination on reduction of hospitalizations and deaths in elderly patients in Rio Grande do Norte, Brazil. Int J Environ Res Public Health 2022; 19(21): 13902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9653712</ArticleId><ArticleId IdType="pubmed">36360782</ArticleId></ArticleIdList></Reference><Reference><Citation>Arregocés-castillo L, Fernández-niño J, Rojas-botero M, et al.. Effectiveness of COVID-19 vaccines in older adults in Colombia : a retrospective, population-based study of the ESPERANZA cohort. Lancet Healthy Longev 2022; 3(4):e242–e252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937302</ArticleId><ArticleId IdType="pubmed">35340743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganasegeran K, Jamil MFA, Ch’ng ASH, et al.. COVID-19 pandemic indicators and variation with vaccinations in Malaysia: a regional-based geo-visualization and geo-ecological regression study. GeoJournal 2024; 89: 114.</Citation></Reference><Reference><Citation>Havers FP, Pham H, Taylor CA, et al.. COVID-19-Associated Hospitalizations AmongVaccinated and UnvaccinatedAdults 18 Years or Older in 13 US States, January 2021 to April 2022. JAMA Intern Med | Orig Investig 2022; 30329: 1071–1081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9459904</ArticleId><ArticleId IdType="pubmed">36074486</ArticleId></ArticleIdList></Reference><Reference><Citation>Katuuk DA, Sony J, Lengkong J, et al.. Management of Covid-19 Vaccination for the Elderly. Budapest Int Res Crit Inst J 2021; 4: 2121–2134.</Citation></Reference><Reference><Citation>Isril I, Harirah Z, Rizaldi A. Evaluation of the Covid 19 vaccine policy for the elderly community in Pekanbaru City. J Transform 2021; 7: 226–240.</Citation></Reference><Reference><Citation>Liu B, Stepien S, Dobbins T, et al.. Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study. Lancet Reg Heal - West Pacific 2023; 40: 100928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10579525</ArticleId><ArticleId IdType="pubmed">37854458</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. Mitigating the impact of COVID-19 on control of vaccine-preventable diseases: a health risk management approach focused on catch-up vaccination (2020). WHO Eur Reg, https://www.who.int/europe/publications/i/item/WHO-EURO-2020-1086-40832-55187 (2021, accessed 6 January 2021).</Citation></Reference><Reference><Citation>Neighbors CE, Sloane R, Pieper CF, et al.. Mitigation behavior prior to COVID-19 vaccination availability is associated with COVID-19 infection and time to vaccination. PLoS One 2023; 18: 1–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10038251</ArticleId><ArticleId IdType="pubmed">36961840</ArticleId></ArticleIdList></Reference><Reference><Citation>
Nations U. Challenges for the protection of older persons and their rights during the COVID-19 pandemic, https://www.un-ilibrary.org/content/books/9789214030607/read (2020, accessed 5 January 2021).</Citation></Reference><Reference><Citation>Carballada AM, Balsa-Barreiro J. Geospatial analysis and mapping strategies for fine-grained and detailed covid-19 data with gis. ISPRS Int J Geo-Information. Epub ahead of print 2021. DOI: 10.3390/ijgi10090602.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijgi10090602</ArticleId></ArticleIdList></Reference><Reference><Citation>De Mello-Sampayo F. Spatial and temporal analysis of COVID-19 in the elderly living in residential care homes in Portugal. Int J Environ Res Public Health. Epub ahead of print 2022. DOI: 10.3390/ijerph19105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19105921</ArticleId><ArticleId IdType="pmc">PMC9140434</ArticleId><ArticleId IdType="pubmed">35627458</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicodemo C, Barzin S, Cavalli N, et al.. Measuring geographical disparities in England at the time of COVID-19: results using a composite indicator of population vulnerability. BMJ Open 2020; 10: e039749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7526277</ArticleId><ArticleId IdType="pubmed">32994257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima M, O’keefe KJ, Wei W, et al.. Geospatial analysis of covid-19: a scoping review. Int J Environ Res Public Health 2021; 18: 1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7956835</ArticleId><ArticleId IdType="pubmed">33673545</ArticleId></ArticleIdList></Reference><Reference><Citation>Karácsonyi D, Dyrting S, Taylor A. A spatial interpretation of Australia’s COVID-vulnerability. Int J Disaster Risk Reduct. Epub ahead of print 2021. DOI: 10.1016/j.ijdrr.2021.102299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdrr.2021.102299</ArticleId><ArticleId IdType="pmc">PMC9587918</ArticleId><ArticleId IdType="pubmed">36311646</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazia N. Spatial variations of COVID-19 risk by age in Toronto, Canada. Geospat Health 2022; 17: 247–255.</Citation><ArticleIdList><ArticleId IdType="pubmed">35860921</ArticleId></ArticleIdList></Reference><Reference><Citation>Syetiawan A, Harimurti M, Prihanto Y. A spatiotemporal analysis of COVID-19 transmission in Jakarta, Indonesia for pandemic decision support. Geospat Health 2022; 17: 85–97.</Citation><ArticleIdList><ArticleId IdType="pubmed">35147009</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum U, Poukka E, Leino T, et al.. High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron. BMC Infect Dis. Epub ahead of print 2022. DOI: 10.1186/s12879-022-07814-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07814-4</ArticleId><ArticleId IdType="pmc">PMC9636823</ArticleId><ArticleId IdType="pubmed">36335289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani OT, Hitchings MDT, Dorion M, et al.. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ; 374. Epub ahead of print 2021. DOI: 10.1136/bmj.n2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2015</ArticleId><ArticleId IdType="pmc">PMC8377801</ArticleId><ArticleId IdType="pubmed">34417194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman Y, Palgi Y, Goodwin R, et al.. Severe Covid-19 vaccine side-effects are rare in older adults yet are linked with depressive symptoms. Am J Geriatr Psychiatry 2022; 30: 115–116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482552</ArticleId><ArticleId IdType="pubmed">34686410</ArticleId></ArticleIdList></Reference><Reference><Citation>Song P, Adeloye D, Acharya Y, et al.. Setting research priorities for global pandemic preparedness: an international consensus and comparison with ChatGPT’s output. J Glob Health. Epub ahead of print 2024. DOI: 10.7189/JOGH.14.04054.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/JOGH.14.04054</ArticleId><ArticleId IdType="pmc">PMC10869134</ArticleId><ArticleId IdType="pubmed">38386716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganasegeran K, Ch’ng ASH, Looi I. What is the estimated COVID-19 reproduction number and the proportion of the population that needs to be immunized to achieve herd immunity in Malaysia? A mathematical epidemiology synthesis. COVID 2021; 1: 13–19.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>